Gene · 6923
Papers1,377
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,377
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical tools for BAZ2A/B biology: discovery of dual and BAZ2B-selective PROTAC degraders. | RSC Med Chem | 2026 | 42626597 | PubTator, text mining | PubMed |
| Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD). | Cancer Metastasis Rev | 2026 | 42593521 | PubTator, text mining | PubMed |
| Elongin B orchestrates chromatin and transcriptional programs in H3K27M-mutant diffuse midline glioma. | bioRxiv | 2026 | 42239282 | PubTator, text mining | PubMed |
| A conserved mechanism for stabilization of viral innate immune antagonists via interaction with Elongin BC. | Proc Natl Acad Sci U S A | 2026 | 42234532 | PubTator, text mining | PubMed |
| Structure of the E3 ligase CRL2ZYG11B with substrates reveals the molecular basis for N-degron recognition and ubiquitination. | Cell Rep | 2026 | 42224082 | PubTator, text mining | PubMed |
| Targeting the Elongin BC-BC-Box Interface: Structural Insights, Peptidic Disruptors and Emerging Small-Molecule Strategies. | Chem Biol Drug Des | 2026 | 42070964 | PubTator, text mining | PubMed |
| Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma. | Cancer Commun (Lond) | 2026 | 41958708 | PubTator, text mining | PubMed |
| Structures of ZYG11B-EloB-EloC-substrate complex reveal mechanisms of CRL2ZYG11B assembly and function. | Nat Commun | 2026 | 41917018 | PubTator, text mining | PubMed |
| Atomic-Scale Mapping of Interfacial Water on Oxide Surfaces via Proton-Resolved NMR and Ab Initio Simulations. | J Am Chem Soc | 2026 | 41837765 | PubTator, text mining | PubMed |
| Emerging Protein Targets in Triple-Negative Breast Cancer: Beyond Conventional Therapy. | Cancers (Basel) | 2026 | 41749871 | PubTator, text mining | PubMed |
| ULK2 suppresses glycolysis to attenuate cisplatin resistance in ovarian cancer organoid via c-Jun phosphorylation. | Sci Prog | 2026 | 41719166 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase mechanism specifying target-directed microRNA degradation. | bioRxiv | 2026 | 41542392 | PubTator, text mining | PubMed |
| Whole-Genome Landscape of Retinal Hemangioblastomas. | Transl Vis Sci Technol | 2026 | 41533848 | PubTator, text mining | PubMed |
| Evolution, composition and functions of cullin E3 ubiquitin ligases in trypanosomes. | Sci Rep | 2025 | 41413177 | PubTator, text mining | PubMed |
| Proteome-Wide Monitoring of Drug Action in Living Cells Using a Novel Label-Free Solvent-Based Shift Assay. | Mol Cell Proteomics | 2025 | 41202878 | PubTator, text mining | PubMed |
| Proteomic signature of aging in bloodstain samples: a preliminary study. | BMC Genomics | 2025 | 41162879 | PubTator, text mining | PubMed |
| TCEB2 promotes M2 polarization of macrophages in triple negative breast cancer by mediating ubiquitination degradation of Slit2 through recruiting NEDD4. | Transl Oncol | 2025 | 41014880 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to CAR T-Cells and How to Overcome Them. | Methods Protoc | 2025 | 40981226 | PubTator, text mining | PubMed |
| Covariation MS uncovers a protein that controls cysteine catabolism. | Nature | 2025 | 40963025 | Swiss-Prot, curated | PubMed |
| Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids. | Commun Biol | 2025 | 40858992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6923/papers